Paul Chang

Lead founder of Ribon Therapeutics, and previously VP of Discovery Biology, Scientific Advisor and SAB member for Ribon.

Previously the Howard and Linda Stern Assistant Professor at the Koch Institute for Integrative Cancer Research at MIT and the Department of Biology at MIT.

Rita Allen Foundation fellow, Sidney Kimmel Foundation for Cancer Research fellow, recipient of a Kathy and Curt Marble Fund award, and multiple awards and grants from the NIH and Biopharma.

Co-Chair and Organizer 2015 FASEB SRC conference, NAD+ Signaling and Metabolism, Chair and Organizer 2017 FASEB SRC conference, NAD+ Signaling and Metabolism.